Table of Content

1 Monoclonal Antibodies Market Overview
1.1 Monoclonal Antibodies Product Scope
1.2 Monoclonal Antibodies Segment by Type
1.2.1 Global Monoclonal Antibodies Sales by Type (2018 & 2024 & 2034)
1.2.2 Erythropoietin (EPO)
1.2.3 Human Growth Hormone (HGH)
1.2.4 Granulocyte- Colony Stimulating Factor (G-CSF)
1.2.5 Monoclonal Antibody (mAb)
1.2.6 Insulin
1.2.7 Interferon (IFN)
1.2.8 Others
1.3 Monoclonal Antibodies Segment by Application
1.3.1 Global Monoclonal Antibodies Sales Comparison by Application (2018 & 2024 & 2034)
1.3.2 Anti-Cancer
1.3.3 Anti-Inflammatory/Autoimmune
1.4 Monoclonal Antibodies Market Estimates and Forecasts (2018-2034)
1.4.1 Global Monoclonal Antibodies Market Size in Value Growth Rate (2018-2034)
1.4.2 Global Monoclonal Antibodies Market Size in Volume Growth Rate (2018-2034)
1.4.3 Global Monoclonal Antibodies Price Trends (2018-2034)
2 Monoclonal Antibodies Estimates and Forecasts by Region
2.1 Global Monoclonal Antibodies Market Size by Region: 2018 VS 2024 VS 2034
2.2 Global Monoclonal Antibodies Retrospective Market Scenario by Region (2018-2023)
2.2.1 Global Monoclonal Antibodies Sales Market Share by Region (2018-2023)
2.2.2 Global Monoclonal Antibodies Revenue Market Share by Region (2018-2023)
2.3 Global Monoclonal Antibodies Market Estimates and Forecasts by Region (2024-2034)
2.3.1 Global Monoclonal Antibodies Sales Estimates and Forecasts by Region (2024-2034)
2.3.2 Global Monoclonal Antibodies Revenue Forecast by Region (2024-2034)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Monoclonal Antibodies Estimates and Projections (2018-2034)
2.4.2 Europe Monoclonal Antibodies Estimates and Projections (2018-2034)
2.4.3 China Monoclonal Antibodies Estimates and Projections (2018-2034)
2.4.4 Japan Monoclonal Antibodies Estimates and Projections (2018-2034)
2.4.5 Southeast Asia Monoclonal Antibodies Estimates and Projections (2018-2034)
2.4.6 India Monoclonal Antibodies Estimates and Projections (2018-2034)
3 Global Monoclonal Antibodies Competition Landscape by Players
3.1 Global Top Monoclonal Antibodies Players by Sales (2018-2023)
3.2 Global Top Monoclonal Antibodies Players by Revenue (2018-2023)
3.3 Global Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Monoclonal Antibodies as of 2024)
3.4 Global Monoclonal Antibodies Average Price by Company (2018-2023)
3.5 Manufacturers Monoclonal Antibodies Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Monoclonal Antibodies Market Size by Type
4.1 Global Monoclonal Antibodies Historic Market Review by Type (2018-2023)
4.1.1 Global Monoclonal Antibodies Sales by Type (2018-2023)
4.1.2 Global Monoclonal Antibodies Revenue by Type (2018-2023)
4.1.3 Global Monoclonal Antibodies Price by Type (2018-2023)
4.2 Global Monoclonal Antibodies Market Estimates and Forecasts by Type (2024-2034)
4.2.1 Global Monoclonal Antibodies Sales Forecast by Type (2024-2034)
4.2.2 Global Monoclonal Antibodies Revenue Forecast by Type (2024-2034)
4.2.3 Global Monoclonal Antibodies Price Forecast by Type (2024-2034)
5 Global Monoclonal Antibodies Market Size by Application
5.1 Global Monoclonal Antibodies Historic Market Review by Application (2018-2023)
5.1.1 Global Monoclonal Antibodies Sales by Application (2018-2023)
5.1.2 Global Monoclonal Antibodies Revenue by Application (2018-2023)
5.1.3 Global Monoclonal Antibodies Price by Application (2018-2023)
5.2 Global Monoclonal Antibodies Market Estimates and Forecasts by Application (2024-2034)
5.2.1 Global Monoclonal Antibodies Sales Forecast by Application (2024-2034)
5.2.2 Global Monoclonal Antibodies Revenue Forecast by Application (2024-2034)
5.2.3 Global Monoclonal Antibodies Price Forecast by Application (2024-2034)
6 United States Monoclonal Antibodies Market Facts & Figures
6.1 United States Monoclonal Antibodies Sales by Company
6.1.1 United States Monoclonal Antibodies Sales by Company (2018-2023)
6.1.2 United States Monoclonal Antibodies Revenue by Company (2018-2023)
6.2 United States Monoclonal Antibodies Sales Breakdown by Type
6.2.1 United States Monoclonal Antibodies Sales Breakdown by Type (2018-2023)
6.2.2 United States Monoclonal Antibodies Sales Breakdown by Type (2024-2034)
6.3 United States Monoclonal Antibodies Sales Breakdown by Application
6.3.1 United States Monoclonal Antibodies Sales Breakdown by Application (2018-2023)
6.3.2 United States Monoclonal Antibodies Sales Breakdown by Application (2024-2034)
7 Europe Monoclonal Antibodies Market Facts & Figures
7.1 Europe Monoclonal Antibodies Sales by Company
7.1.1 Europe Monoclonal Antibodies Sales by Company (2018-2023)
7.1.2 Europe Monoclonal Antibodies Revenue by Company (2018-2023)
7.2 Europe Monoclonal Antibodies Sales Breakdown by Type
7.2.1 Europe Monoclonal Antibodies Sales Breakdown by Type (2018-2023)
7.2.2 Europe Monoclonal Antibodies Sales Breakdown by Type (2024-2034)
7.3 Europe Monoclonal Antibodies Sales Breakdown by Application
7.3.1 Europe Monoclonal Antibodies Sales Breakdown by Application (2018-2023)
7.3.2 Europe Monoclonal Antibodies Sales Breakdown by Application (2024-2034)
8 China Monoclonal Antibodies Market Facts & Figures
8.1 China Monoclonal Antibodies Sales by Company
8.1.1 China Monoclonal Antibodies Sales by Company (2018-2023)
8.1.2 China Monoclonal Antibodies Revenue by Company (2018-2023)
8.2 China Monoclonal Antibodies Sales Breakdown by Type
8.2.1 China Monoclonal Antibodies Sales Breakdown by Type (2018-2023)
8.2.2 China Monoclonal Antibodies Sales Breakdown by Type (2024-2034)
8.3 China Monoclonal Antibodies Sales Breakdown by Application
8.3.1 China Monoclonal Antibodies Sales Breakdown by Application (2018-2023)
8.3.2 China Monoclonal Antibodies Sales Breakdown by Application (2024-2034)
9 Japan Monoclonal Antibodies Market Facts & Figures
9.1 Japan Monoclonal Antibodies Sales by Company
9.1.1 Japan Monoclonal Antibodies Sales by Company (2018-2023)
9.1.2 Japan Monoclonal Antibodies Revenue by Company (2018-2023)
9.2 Japan Monoclonal Antibodies Sales Breakdown by Type
9.2.1 Japan Monoclonal Antibodies Sales Breakdown by Type (2018-2023)
9.2.2 Japan Monoclonal Antibodies Sales Breakdown by Type (2024-2034)
9.3 Japan Monoclonal Antibodies Sales Breakdown by Application
9.3.1 Japan Monoclonal Antibodies Sales Breakdown by Application (2018-2023)
9.3.2 Japan Monoclonal Antibodies Sales Breakdown by Application (2024-2034)
10 Southeast Asia Monoclonal Antibodies Market Facts & Figures
10.1 Southeast Asia Monoclonal Antibodies Sales by Company
10.1.1 Southeast Asia Monoclonal Antibodies Sales by Company (2018-2023)
10.1.2 Southeast Asia Monoclonal Antibodies Revenue by Company (2018-2023)
10.2 Southeast Asia Monoclonal Antibodies Sales Breakdown by Type
10.2.1 Southeast Asia Monoclonal Antibodies Sales Breakdown by Type (2018-2023)
10.2.2 Southeast Asia Monoclonal Antibodies Sales Breakdown by Type (2024-2034)
10.3 Southeast Asia Monoclonal Antibodies Sales Breakdown by Application
10.3.1 Southeast Asia Monoclonal Antibodies Sales Breakdown by Application (2018-2023)
10.3.2 Southeast Asia Monoclonal Antibodies Sales Breakdown by Application (2024-2034)
11 India Monoclonal Antibodies Market Facts & Figures
11.1 India Monoclonal Antibodies Sales by Company
11.1.1 India Monoclonal Antibodies Sales by Company (2018-2023)
11.1.2 India Monoclonal Antibodies Revenue by Company (2018-2023)
11.2 India Monoclonal Antibodies Sales Breakdown by Type
11.2.1 India Monoclonal Antibodies Sales Breakdown by Type (2018-2023)
11.2.2 India Monoclonal Antibodies Sales Breakdown by Type (2024-2034)
11.3 India Monoclonal Antibodies Sales Breakdown by Application
11.3.1 India Monoclonal Antibodies Sales Breakdown by Application (2018-2023)
11.3.2 India Monoclonal Antibodies Sales Breakdown by Application (2024-2034)
12 Company Profiles and Key Figures in Monoclonal Antibodies Business
12.1 Biocon
12.1.1 Biocon Corporation Information
12.1.2 Biocon Business Overview
12.1.3 Biocon Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2023)
12.1.4 Biocon Monoclonal Antibodies Products Offered
12.1.5 Biocon Recent Development
12.2 Celltrion
12.2.1 Celltrion Corporation Information
12.2.2 Celltrion Business Overview
12.2.3 Celltrion Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2023)
12.2.4 Celltrion Monoclonal Antibodies Products Offered
12.2.5 Celltrion Recent Development
12.3 Dr. Reddy's Laboratories
12.3.1 Dr. Reddy's Laboratories Corporation Information
12.3.2 Dr. Reddy's Laboratories Business Overview
12.3.3 Dr. Reddy's Laboratories Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2023)
12.3.4 Dr. Reddy's Laboratories Monoclonal Antibodies Products Offered
12.3.5 Dr. Reddy's Laboratories Recent Development
12.4 Hospira
12.4.1 Hospira Corporation Information
12.4.2 Hospira Business Overview
12.4.3 Hospira Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2023)
12.4.4 Hospira Monoclonal Antibodies Products Offered
12.4.5 Hospira Recent Development
12.5 3SBio
12.5.1 3SBio Corporation Information
12.5.2 3SBio Business Overview
12.5.3 3SBio Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2023)
12.5.4 3SBio Monoclonal Antibodies Products Offered
12.5.5 3SBio Recent Development
12.6 Accord Healthcare
12.6.1 Accord Healthcare Corporation Information
12.6.2 Accord Healthcare Business Overview
12.6.3 Accord Healthcare Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2023)
12.6.4 Accord Healthcare Monoclonal Antibodies Products Offered
12.6.5 Accord Healthcare Recent Development
12.7 AET Biotech
12.7.1 AET Biotech Corporation Information
12.7.2 AET Biotech Business Overview
12.7.3 AET Biotech Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2023)
12.7.4 AET Biotech Monoclonal Antibodies Products Offered
12.7.5 AET Biotech Recent Development
12.8 Allergan
12.8.1 Allergan Corporation Information
12.8.2 Allergan Business Overview
12.8.3 Allergan Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2023)
12.8.4 Allergan Monoclonal Antibodies Products Offered
12.8.5 Allergan Recent Development
12.9 Amega Biotech
12.9.1 Amega Biotech Corporation Information
12.9.2 Amega Biotech Business Overview
12.9.3 Amega Biotech Monoclonal Antibodies Sales, Revenue and Gross Margin (2018-2023)
12.9.4 Amega Biotech Monoclonal Antibodies Products Offered
12.9.5 Amega Biotech Recent Development
13 Monoclonal Antibodies Manufacturing Cost Analysis
13.1 Monoclonal Antibodies Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Monoclonal Antibodies
13.4 Monoclonal Antibodies Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Monoclonal Antibodies Distributors List
14.3 Monoclonal Antibodies Customers
15 Market Dynamics
15.1 Monoclonal Antibodies Industry Trends
15.2 Monoclonal Antibodies Market Drivers
15.3 Monoclonal Antibodies Market Challenges
15.4 Monoclonal Antibodies Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Monoclonal Antibodies Sales (US$ Million) Growth Rate by Type (2018 & 2024 & 2034)
Table 2. Global Monoclonal Antibodies Sales ((US$ Million)) Comparison by Application (2018 & 2024 & 2034)
Table 3. Global Monoclonal Antibodies Market Size (US$ Million) by Region: 2018 VS 2024 VS 2034
Table 4. Global Monoclonal Antibodies Sales (Units) by Region (2018-2023)
Table 5. Global Monoclonal Antibodies Sales Market Share by Region (2018-2023)
Table 6. Global Monoclonal Antibodies Revenue (US$ Million) Market Share by Region (2018-2023))
Table 7. Global Monoclonal Antibodies Revenue Share by Region (2018-2023)
Table 8. Global Monoclonal Antibodies Sales (Units) Forecast by Region (2024-2034)
Table 9. Global Monoclonal Antibodies Sales Market Share Forecast by Region (2024-2034)
Table 10. Global Monoclonal Antibodies Revenue (US$ Million) Forecast by Region (2024-2034)
Table 11. Global Monoclonal Antibodies Revenue Share Forecast by Region (2024-2034)
Table 12. Global Monoclonal Antibodies Sales by Company (Units) & (2018-2023)
Table 13. Global Monoclonal Antibodies Sales Share by Company (2018-2023)
Table 14. Global Monoclonal Antibodies Revenue by Company (US$ Million) & (2018-2023)
Table 15. Global Monoclonal Antibodies Revenue Share by Company (2018-2023)
Table 16. Global Monoclonal Antibodies by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monoclonal Antibodies as of 2024)
Table 17. Global Market Monoclonal Antibodies Average Price by Company (USD/Unit) & (2018-2023)
Table 18. Manufacturers Monoclonal Antibodies Manufacturing Sites and Area Served
Table 19. Manufacturers Monoclonal Antibodies Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Monoclonal Antibodies Sales by Type (2018-2023) & (Units)
Table 22. Global Monoclonal Antibodies Sales Share by Type (2018-2023)
Table 23. Global Monoclonal Antibodies Revenue by Type (2018-2023) & (US$ Million)
Table 24. Global Monoclonal Antibodies Price by Type (2018-2023) & (USD/Unit)
Table 25. Global Monoclonal Antibodies Sales by Type (2024-2034)
Table 26. Global Monoclonal Antibodies Revenue by Type (2024-2034) & (US$ Million)
Table 27. Global Monoclonal Antibodies Revenue Share by Type (2024-2034)
Table 28. Global Monoclonal Antibodies Price by Type (2024-2034) & (USD/Unit)
Table 29. Global Monoclonal Antibodies Sales by Application (2018-2023) & (Units)
Table 30. Global Monoclonal Antibodies Sales Share by Application (2018-2023)
Table 31. Global Monoclonal Antibodies Revenue by Application (2018-2023) & (US$ Million)
Table 32. Global Monoclonal Antibodies Price by Application (2018-2023) & (USD/Unit)
Table 33. Global Monoclonal Antibodies Sales by Application (2024-2034) & (Units)
Table 34. Global Monoclonal Antibodies Sales Share by Application (2024-2034)
Table 35. Global Monoclonal Antibodies Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Monoclonal Antibodies Revenue Share by Application (2024-2034)
Table 37. Global Monoclonal Antibodies Price by Application (2024-2034) & (USD/Unit)
Table 38. United States Monoclonal Antibodies Sales by Company (2018-2023) & (Units)
Table 39. United States Monoclonal Antibodies Sales Market Share by Company (2018-2023)
Table 40. United States Monoclonal Antibodies Revenue by Company (2018-2023) & (US$ Million)
Table 41. United States Monoclonal Antibodies Revenue Market Share by Company (2018-2023)
Table 42. United States Monoclonal Antibodies Sales by Type (2018-2023) & (Units)
Table 43. United States Monoclonal Antibodies Sales Market Share by Type (2018-2023)
Table 44. United States Monoclonal Antibodies Sales by Type (2024-2034) & (Units)
Table 45. United States Monoclonal Antibodies Sales Market Share by Type (2024-2034)
Table 46. United States Monoclonal Antibodies Sales by Application (2018-2023) & (Units)
Table 47. United States Monoclonal Antibodies Sales Market Share by Application (2018-2023)
Table 48. United States Monoclonal Antibodies Sales by Application (2024-2034) & (Units)
Table 49. United States Monoclonal Antibodies Sales Market Share by Application (2024-2034)
Table 50. Europe Monoclonal Antibodies Sales by Company (2018-2023) & (Units)
Table 51. Europe Monoclonal Antibodies Sales Market Share by Company (2018-2023)
Table 52. Europe Monoclonal Antibodies Revenue by Company (2018-2023) & (US$ Million)
Table 53. Europe Monoclonal Antibodies Revenue Market Share by Company (2018-2023)
Table 54. Europe Monoclonal Antibodies Sales by Type (2018-2023) & (Units)
Table 55. Europe Monoclonal Antibodies Sales Market Share by Type (2018-2023)
Table 56. Europe Monoclonal Antibodies Sales by Type (2024-2034) & (Units)
Table 57. Europe Monoclonal Antibodies Sales Market Share by Type (2024-2034)
Table 58. Europe Monoclonal Antibodies Sales by Application (2018-2023) & (Units)
Table 59. Europe Monoclonal Antibodies Sales Market Share by Application (2018-2023)
Table 60. Europe Monoclonal Antibodies Sales by Application (2024-2034) & (Units)
Table 61. Europe Monoclonal Antibodies Sales Market Share by Application (2024-2034)
Table 62. China Monoclonal Antibodies Sales by Company (2018-2023) & (Units)
Table 63. China Monoclonal Antibodies Sales Market Share by Company (2018-2023)
Table 64. China Monoclonal Antibodies Revenue by Company (2018-2023) & (US$ Million)
Table 65. China Monoclonal Antibodies Revenue Market Share by Company (2018-2023)
Table 66. China Monoclonal Antibodies Sales by Type (2018-2023) & (Units)
Table 67. China Monoclonal Antibodies Sales Market Share by Type (2018-2023)
Table 68. China Monoclonal Antibodies Sales by Type (2024-2034) & (Units)
Table 69. China Monoclonal Antibodies Sales Market Share by Type (2024-2034)
Table 70. China Monoclonal Antibodies Sales by Application (2018-2023) & (Units)
Table 71. China Monoclonal Antibodies Sales Market Share by Application (2018-2023)
Table 72. China Monoclonal Antibodies Sales by Application (2024-2034) & (Units)
Table 73. China Monoclonal Antibodies Sales Market Share by Application (2024-2034)
Table 74. Japan Monoclonal Antibodies Sales by Company (2018-2023) & (Units)
Table 75. Japan Monoclonal Antibodies Sales Market Share by Company (2018-2023)
Table 76. Japan Monoclonal Antibodies Revenue by Company (2018-2023) & (US$ Million)
Table 77. Japan Monoclonal Antibodies Revenue Market Share by Company (2018-2023)
Table 78. Japan Monoclonal Antibodies Sales by Type (2018-2023) & (Units)
Table 79. Japan Monoclonal Antibodies Sales Market Share by Type (2018-2023)
Table 80. Japan Monoclonal Antibodies Sales by Type (2024-2034) & (Units)
Table 81. Japan Monoclonal Antibodies Sales Market Share by Type (2024-2034)
Table 82. Japan Monoclonal Antibodies Sales by Application (2018-2023) & (Units)
Table 83. Japan Monoclonal Antibodies Sales Market Share by Application (2018-2023)
Table 84. Japan Monoclonal Antibodies Sales by Application (2024-2034) & (Units)
Table 85. Japan Monoclonal Antibodies Sales Market Share by Application (2024-2034)
Table 86. Southeast Asia Monoclonal Antibodies Sales by Company (2018-2023) & (Units)
Table 87. Southeast Asia Monoclonal Antibodies Sales Market Share by Company (2018-2023)
Table 88. Southeast Asia Monoclonal Antibodies Revenue by Company (2018-2023) & (US$ Million)
Table 89. Southeast Asia Monoclonal Antibodies Revenue Market Share by Company (2018-2023)
Table 90. Southeast Asia Monoclonal Antibodies Sales by Type (2018-2023) & (Units)
Table 91. Southeast Asia Monoclonal Antibodies Sales Market Share by Type (2018-2023)
Table 92. Southeast Asia Monoclonal Antibodies Sales by Type (2024-2034) & (Units)
Table 93. Southeast Asia Monoclonal Antibodies Sales Market Share by Type (2024-2034)
Table 94. Southeast Asia Monoclonal Antibodies Sales by Application (2018-2023) & (Units)
Table 95. Southeast Asia Monoclonal Antibodies Sales Market Share by Application (2018-2023)
Table 96. Southeast Asia Monoclonal Antibodies Sales by Application (2024-2034) & (Units)
Table 97. Southeast Asia Monoclonal Antibodies Sales Market Share by Application (2024-2034)
Table 98. India Monoclonal Antibodies Sales by Company (2018-2023) & (Units)
Table 99. India Monoclonal Antibodies Sales Market Share by Company (2018-2023)
Table 100. India Monoclonal Antibodies Revenue by Company (2018-2023) & (US$ Million)
Table 101. India Monoclonal Antibodies Revenue Market Share by Company (2018-2023)
Table 102. India Monoclonal Antibodies Sales by Type (2018-2023) & (Units)
Table 103. India Monoclonal Antibodies Sales Market Share by Type (2018-2023)
Table 104. India Monoclonal Antibodies Sales by Type (2024-2034) & (Units)
Table 105. India Monoclonal Antibodies Sales Market Share by Type (2024-2034)
Table 106. India Monoclonal Antibodies Sales by Application (2018-2023) & (Units)
Table 107. India Monoclonal Antibodies Sales Market Share by Application (2018-2023)
Table 108. India Monoclonal Antibodies Sales by Application (2024-2034) & (Units)
Table 109. India Monoclonal Antibodies Sales Market Share by Application (2024-2034)
Table 110. Biocon Corporation Information
Table 111. Biocon Description and Business Overview
Table 112. Biocon Monoclonal Antibodies Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. Biocon Monoclonal Antibodies Product
Table 114. Biocon Recent Development
Table 115. Celltrion Corporation Information
Table 116. Celltrion Description and Business Overview
Table 117. Celltrion Monoclonal Antibodies Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 118. Celltrion Monoclonal Antibodies Product
Table 119. Celltrion Recent Development
Table 120. Dr. Reddy's Laboratories Corporation Information
Table 121. Dr. Reddy's Laboratories Description and Business Overview
Table 122. Dr. Reddy's Laboratories Monoclonal Antibodies Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 123. Dr. Reddy's Laboratories Monoclonal Antibodies Product
Table 124. Dr. Reddy's Laboratories Recent Development
Table 125. Hospira Corporation Information
Table 126. Hospira Description and Business Overview
Table 127. Hospira Monoclonal Antibodies Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 128. Hospira Monoclonal Antibodies Product
Table 129. Hospira Recent Development
Table 130. 3SBio Corporation Information
Table 131. 3SBio Description and Business Overview
Table 132. 3SBio Monoclonal Antibodies Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 133. 3SBio Monoclonal Antibodies Product
Table 134. 3SBio Recent Development
Table 135. Accord Healthcare Corporation Information
Table 136. Accord Healthcare Description and Business Overview
Table 137. Accord Healthcare Monoclonal Antibodies Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 138. Accord Healthcare Monoclonal Antibodies Product
Table 139. Accord Healthcare Recent Development
Table 140. AET Biotech Corporation Information
Table 141. AET Biotech Description and Business Overview
Table 142. AET Biotech Monoclonal Antibodies Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 143. AET Biotech Monoclonal Antibodies Product
Table 144. AET Biotech Recent Development
Table 145. Allergan Corporation Information
Table 146. Allergan Monoclonal Antibodies Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 147. Allergan Description and Business Overview
Table 148. Allergan Monoclonal Antibodies Product
Table 149. Allergan Recent Development
Table 150. Amega Biotech Corporation Information
Table 151. Amega Biotech Monoclonal Antibodies Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 152. Amega Biotech Description and Business Overview
Table 153. Amega Biotech Monoclonal Antibodies Product
Table 154. Amega Biotech Recent Development
Table 155. Production Base and Market Concentration Rate of Raw Material
Table 156. Key Suppliers of Raw Materials
Table 157. Monoclonal Antibodies Distributors List
Table 158. Monoclonal Antibodies Customers List
Table 159. Monoclonal Antibodies Market Trends
Table 160. Monoclonal Antibodies Market Drivers
Table 161. Monoclonal Antibodies Market Challenges
Table 162. Monoclonal Antibodies Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Monoclonal Antibodies Product Picture
Figure 2. Global Monoclonal Antibodies Sales (US$ Million) by Type (2018 & 2024 & 2034)
Figure 3. Global Monoclonal Antibodies Sales Market Share by Type in 2024 & 2034
Figure 4. Erythropoietin (EPO) Product Picture
Figure 5. Human Growth Hormone (HGH) Product Picture
Figure 6. Granulocyte- Colony Stimulating Factor (G-CSF) Product Picture
Figure 7. Monoclonal Antibody (mAb) Product Picture
Figure 8. Insulin Product Picture
Figure 9. Interferon (IFN) Product Picture
Figure 10. Others Product Picture
Figure 11. Global Monoclonal Antibodies Sales (US$ Million) by Application (2018 & 2024 & 2034)
Figure 12. Global Monoclonal Antibodies Sales Market Share by Application in 2024 & 2034
Figure 13. Anti-Cancer Examples
Figure 14. Anti-Inflammatory/Autoimmune Examples
Figure 15. Global Monoclonal Antibodies Sales, (US$ Million), 2018 VS 2024 VS 2034
Figure 16. Global Monoclonal Antibodies Sales Growth Rate (2018-2034) & (US$ Million)
Figure 17. Global Monoclonal Antibodies Sales (Units) Growth Rate (2018-2034)
Figure 18. Global Monoclonal Antibodies Price Trends Growth Rate (2018-2034) & (USD/Unit)
Figure 19. Global Market Monoclonal Antibodies Market Size (US$ Million) by Region:2018 VS 2024 VS 2034
Figure 20. Global Monoclonal Antibodies Revenue Market Share by Region: 2018 VS 2024
Figure 21. United States Monoclonal Antibodies Revenue (US$ Million) Growth Rate (2018-2034)
Figure 22. United States Monoclonal Antibodies Sales (Units) Growth Rate (2018-2034)
Figure 23. Europe Monoclonal Antibodies Revenue (US$ Million) Growth Rate (2018-2034)
Figure 24. Europe Monoclonal Antibodies Sales (US$ Million) Growth Rate (2018-2034)
Figure 25. China Monoclonal Antibodies Revenue (US$ Million) Growth Rate (2018-2034)
Figure 26. China Monoclonal Antibodies Sales (US$ Million) and Growth Rate (2018-2034)
Figure 27. Japan Monoclonal Antibodies Revenue (US$ Million) Growth Rate (2018-2034)
Figure 28. Japan Monoclonal Antibodies Sales (US$ Million) Growth Rate (2018-2034)
Figure 29. Southeast Asia Monoclonal Antibodies Revenue (US$ Million) Growth Rate (2018-2034)
Figure 30. Southeast Asia Monoclonal Antibodies Sales (US$ Million) Growth Rate (2018-2034)
Figure 31. India Monoclonal Antibodies Revenue (US$ Million) Growth Rate (2018-2034)
Figure 32. India Monoclonal Antibodies Sales (US$ Million) Growth Rate (2018-2034)
Figure 33. Global 5 Largest Monoclonal Antibodies Players Market Share by Revenue in Monoclonal Antibodies: 2018 & 2024
Figure 34. Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 35. Global Monoclonal Antibodies Revenue Share by Type (2018-2023)
Figure 36. Global Monoclonal Antibodies Sales Share by Type (2024-2034)
Figure 37. Global Monoclonal Antibodies Revenue Share by Type (2024-2034)
Figure 38. Global Monoclonal Antibodies Revenue Share by Application (2018-2023)
Figure 39. Global Monoclonal Antibodies Revenue Growth Rate by Application in 2018 & 2024
Figure 40. Global Monoclonal Antibodies Sales Share by Application (2024-2034)
Figure 41. Global Monoclonal Antibodies Revenue Share by Application (2024-2034)
Figure 42. Key Raw Materials Price Trend
Figure 43. Manufacturing Cost Structure of Monoclonal Antibodies
Figure 44. Manufacturing Process Analysis of Monoclonal Antibodies
Figure 45. Monoclonal Antibodies Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed